CN102858333A - 呼吸紊乱的治疗 - Google Patents
呼吸紊乱的治疗 Download PDFInfo
- Publication number
- CN102858333A CN102858333A CN2011800180526A CN201180018052A CN102858333A CN 102858333 A CN102858333 A CN 102858333A CN 2011800180526 A CN2011800180526 A CN 2011800180526A CN 201180018052 A CN201180018052 A CN 201180018052A CN 102858333 A CN102858333 A CN 102858333A
- Authority
- CN
- China
- Prior art keywords
- compositions
- treatment
- nsaid
- oil
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Abstract
Description
Claims (48)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1001912.3 | 2010-02-05 | ||
GBGB1001912.3A GB201001912D0 (en) | 2010-02-05 | 2010-02-05 | Treatment of respiratory disorders |
GB1015878A GB2477590A (en) | 2010-02-05 | 2010-09-22 | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
GB1015878.0 | 2010-09-22 | ||
PCT/GB2011/050189 WO2011095814A1 (en) | 2010-02-05 | 2011-02-04 | Treatment of respiratory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102858333A true CN102858333A (zh) | 2013-01-02 |
Family
ID=43927856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011800180526A Pending CN102858333A (zh) | 2010-02-05 | 2011-02-04 | 呼吸紊乱的治疗 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20130178448A1 (zh) |
EP (1) | EP2531188A1 (zh) |
JP (1) | JP2013518869A (zh) |
CN (1) | CN102858333A (zh) |
AU (1) | AU2011212256A1 (zh) |
CA (1) | CA2788766A1 (zh) |
GB (1) | GB2477590A (zh) |
MX (1) | MX2012009052A (zh) |
NZ (1) | NZ601594A (zh) |
RU (1) | RU2012137785A (zh) |
SG (2) | SG183176A1 (zh) |
WO (1) | WO2011095814A1 (zh) |
ZA (1) | ZA201205829B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103282021A (zh) * | 2010-10-29 | 2013-09-04 | 比蔻匹亚有限公司 | 炎症性疾病 |
CN103893171A (zh) * | 2014-04-19 | 2014-07-02 | 武汉胜达康生物科技有限公司 | 盐酸苄达明在制备治疗或预防流感病毒感染药物中的应用 |
WO2019047283A1 (zh) * | 2017-09-08 | 2019-03-14 | 中国科学院微生物研究所 | 调控a型和b型流感病毒核蛋白出核的关键氨基酸位点及其作为抗流感病毒药物靶点的用途 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
MX364229B (es) * | 2011-02-04 | 2019-04-17 | Infirst Healthcare Ltd | Composiciones y metodos para tratar enfermedades cardiovasculares. |
WO2013049749A2 (en) | 2011-09-29 | 2013-04-04 | Plx Pharma Inc. | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
WO2013143688A1 (en) | 2012-03-26 | 2013-10-03 | Glatt Ag | Taste-masked ibuprofen granules |
US20150343139A1 (en) * | 2014-05-30 | 2015-12-03 | Boston Scientific Scimed, Inc. | Implantable pumps and related methods of use |
AR102172A1 (es) | 2015-10-05 | 2017-02-08 | Química Luar S R L | Una composición farmacéutica bactericida y virucida |
WO2021195319A1 (en) | 2020-03-26 | 2021-09-30 | Plx Opco Inc. | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME |
WO2022119756A1 (en) * | 2020-12-04 | 2022-06-09 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for inhibiting m pro protease activity and for preventing and treating sars-cov-2 infection |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571400A (en) * | 1984-12-18 | 1986-02-18 | Belleview Pharmaceutical, Inc. | Dihydrocodeine/ibuprofen pharmaceutical compositions and method |
EP0306060A2 (en) * | 1984-01-16 | 1989-03-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US4918103A (en) * | 1988-07-25 | 1990-04-17 | Formulations Development Labs | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5011852A (en) * | 1988-07-25 | 1991-04-30 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5059626A (en) * | 1988-07-25 | 1991-10-22 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
WO1998013073A1 (en) * | 1996-09-24 | 1998-04-02 | Board Of Regents, The University Of Texas System | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN |
WO1998025595A2 (en) * | 1996-12-10 | 1998-06-18 | The Boots Company Plc | Aqueous drink composition comprising ibuprofen |
US20040024057A1 (en) * | 2002-07-03 | 2004-02-05 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
WO2004082588A2 (en) * | 2003-03-20 | 2004-09-30 | Pharmacia Corporation | Dispersible formulation of an anti-inflammatory agent |
US20040253276A1 (en) * | 2001-08-03 | 2004-12-16 | Jun Sato | Stable emulsion composition |
WO2005009436A1 (en) * | 2003-07-31 | 2005-02-03 | Pharmacia & Upjohn Company Llc | Dispersible formulation of an anti-inflammatory agent |
WO2006099325A2 (en) * | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
CN101500545A (zh) * | 2006-06-30 | 2009-08-05 | 麦克内尔-Ppc股份有限公司 | 含布洛芬的液体填充硬胶囊 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684666A (en) * | 1986-08-19 | 1987-08-04 | Haas Pharmaceuticals, Inc. | Stabilized liquid analgesic compositions |
CA1323306C (en) * | 1987-03-05 | 1993-10-19 | Mircea C. Popescu | Pharmacological agent-lipid solution preparation |
ES2181673T3 (es) * | 1991-05-01 | 2003-03-01 | Jackson H M Found Military Med | Procedimiento de tratamiento de las enfermedades respiratorias infecciosas. |
JPH069381A (ja) * | 1992-03-26 | 1994-01-18 | Toyo Capsule Kk | イブプロフェン含有軟カプセル剤 |
AU6390096A (en) * | 1995-07-20 | 1997-02-18 | Pharmacia & Upjohn Company | Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules |
US6319513B1 (en) * | 1998-08-24 | 2001-11-20 | The Procter & Gamble Company | Oral liquid mucoadhesive compounds |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
CA2431606C (en) * | 2000-12-19 | 2011-07-19 | The Board Of Regents Of The University Of Texas System | Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
US20020192161A1 (en) * | 2001-04-10 | 2002-12-19 | Fahkreddin Jamali | Animal model for evaluating analgesics |
US20030232097A1 (en) * | 2002-06-17 | 2003-12-18 | Strides Inc. | Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen |
KR100507771B1 (ko) * | 2002-11-08 | 2005-08-17 | 한미약품 주식회사 | 난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법 |
IL159729A0 (en) * | 2004-01-06 | 2004-06-20 | Doron I Friedman | Non-aqueous composition for oral delivery of insoluble bioactive agents |
BRPI0506764A (pt) * | 2004-01-09 | 2007-05-22 | Wyeth Corp | microemulsões para composições farmacêuticas |
US20070092559A1 (en) * | 2005-10-24 | 2007-04-26 | Jinghua Yuan | Liquid dosage forms having enteric properties of delayed and then sustained release |
JP2008143807A (ja) * | 2006-12-07 | 2008-06-26 | Sato Pharmaceutical Co Ltd | 感冒薬カプセル剤及びその製造方法 |
WO2009069139A1 (en) * | 2007-11-28 | 2009-06-04 | Alkem Laboratories Ltd. | Dosage form providing an ibuprofen-containing liquid fill |
JP2009155282A (ja) * | 2007-12-27 | 2009-07-16 | Kowa Co | 固体分散体含有医薬組成物 |
CA2743551C (en) * | 2008-11-19 | 2017-08-15 | Merial Limited | Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol |
US8592400B2 (en) * | 2009-02-27 | 2013-11-26 | Boehringer Ingelheim International Gmbh | Drug combinations containing PDE4 inhibitors and NSAIDs |
CA2753604A1 (en) * | 2009-02-27 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Drug combinations containing pde4-inhibitors and nsaids |
-
2010
- 2010-09-22 GB GB1015878A patent/GB2477590A/en not_active Withdrawn
-
2011
- 2011-02-04 US US13/576,758 patent/US20130178448A1/en not_active Abandoned
- 2011-02-04 RU RU2012137785/15A patent/RU2012137785A/ru not_active Application Discontinuation
- 2011-02-04 CA CA2788766A patent/CA2788766A1/en not_active Abandoned
- 2011-02-04 WO PCT/GB2011/050189 patent/WO2011095814A1/en active Application Filing
- 2011-02-04 NZ NZ601594A patent/NZ601594A/en not_active IP Right Cessation
- 2011-02-04 MX MX2012009052A patent/MX2012009052A/es active IP Right Grant
- 2011-02-04 JP JP2012551685A patent/JP2013518869A/ja active Pending
- 2011-02-04 EP EP11702694A patent/EP2531188A1/en not_active Withdrawn
- 2011-02-04 SG SG2012057865A patent/SG183176A1/en unknown
- 2011-02-04 AU AU2011212256A patent/AU2011212256A1/en not_active Abandoned
- 2011-02-04 CN CN2011800180526A patent/CN102858333A/zh active Pending
- 2011-02-04 SG SG10201500899VA patent/SG10201500899VA/en unknown
-
2012
- 2012-08-02 ZA ZA2012/05829A patent/ZA201205829B/en unknown
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306060A2 (en) * | 1984-01-16 | 1989-03-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US4571400A (en) * | 1984-12-18 | 1986-02-18 | Belleview Pharmaceutical, Inc. | Dihydrocodeine/ibuprofen pharmaceutical compositions and method |
US4918103A (en) * | 1988-07-25 | 1990-04-17 | Formulations Development Labs | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5011852A (en) * | 1988-07-25 | 1991-04-30 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5059626A (en) * | 1988-07-25 | 1991-10-22 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
US5552160A (en) * | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
WO1998013073A1 (en) * | 1996-09-24 | 1998-04-02 | Board Of Regents, The University Of Texas System | METHODS OF ENHANCING THE THERAPEUTIC ACTIVITY OF NSAIDs AND COMPOSITIONS OF ZWITTERIONIC PHOSPHOLIPIDS USEFUL THEREIN |
WO1998025595A2 (en) * | 1996-12-10 | 1998-06-18 | The Boots Company Plc | Aqueous drink composition comprising ibuprofen |
US20040253276A1 (en) * | 2001-08-03 | 2004-12-16 | Jun Sato | Stable emulsion composition |
US20040024057A1 (en) * | 2002-07-03 | 2004-02-05 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
WO2004082588A2 (en) * | 2003-03-20 | 2004-09-30 | Pharmacia Corporation | Dispersible formulation of an anti-inflammatory agent |
WO2004082588A3 (en) * | 2003-03-20 | 2004-12-23 | Pharmacia Corp | Dispersible formulation of an anti-inflammatory agent |
WO2005009436A1 (en) * | 2003-07-31 | 2005-02-03 | Pharmacia & Upjohn Company Llc | Dispersible formulation of an anti-inflammatory agent |
WO2006099325A2 (en) * | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Methods of treating ear infections |
WO2006099325A3 (en) * | 2005-03-10 | 2007-03-29 | 3M Innovative Properties Co | Methods of treating ear infections |
CN101500545A (zh) * | 2006-06-30 | 2009-08-05 | 麦克内尔-Ppc股份有限公司 | 含布洛芬的液体填充硬胶囊 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103282021A (zh) * | 2010-10-29 | 2013-09-04 | 比蔻匹亚有限公司 | 炎症性疾病 |
CN103893171A (zh) * | 2014-04-19 | 2014-07-02 | 武汉胜达康生物科技有限公司 | 盐酸苄达明在制备治疗或预防流感病毒感染药物中的应用 |
CN103893171B (zh) * | 2014-04-19 | 2016-05-25 | 武汉胜达康生物科技有限公司 | 盐酸苄达明在制备治疗或预防流感病毒感染药物中的应用 |
WO2019047283A1 (zh) * | 2017-09-08 | 2019-03-14 | 中国科学院微生物研究所 | 调控a型和b型流感病毒核蛋白出核的关键氨基酸位点及其作为抗流感病毒药物靶点的用途 |
Also Published As
Publication number | Publication date |
---|---|
GB2477590A (en) | 2011-08-10 |
JP2013518869A (ja) | 2013-05-23 |
SG10201500899VA (en) | 2015-04-29 |
WO2011095814A1 (en) | 2011-08-11 |
ZA201205829B (en) | 2013-05-29 |
US20130178448A1 (en) | 2013-07-11 |
AU2011212256A1 (en) | 2012-08-23 |
EP2531188A1 (en) | 2012-12-12 |
GB201015878D0 (en) | 2010-10-27 |
CA2788766A1 (en) | 2011-08-11 |
MX2012009052A (es) | 2012-11-29 |
RU2012137785A (ru) | 2014-03-10 |
NZ601594A (en) | 2014-10-31 |
SG183176A1 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102858333A (zh) | 呼吸紊乱的治疗 | |
US10653778B2 (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases | |
CN103282021A (zh) | 炎症性疾病 | |
RU2680801C2 (ru) | Композиции и способы для лечения хронического воспаления и воспалительных заболеваний | |
CN103391768A (zh) | 治疗慢性炎症和炎性疾病的组合物和方法 | |
CN105324114A (zh) | 虾青素抗炎增效组合 | |
US20200330436A1 (en) | Compositions and Methods for Treatment and Prevention of Pyrexia in Horses | |
TWI327913B (en) | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid | |
CN1813733A (zh) | 维生素e烟酸酯脂质微球注射液及其制备方法 | |
CN105055313B (zh) | 一种畜禽使用的复方磺胺类纳米乳制剂及其制备方法 | |
JP6100510B2 (ja) | 抗感冒剤 | |
CN102470122A (zh) | 用于长期使用nsaid的药物 | |
CN104274397A (zh) | 一种含匹多莫德悬浮剂及其制备方法 | |
CN101987199A (zh) | 一种用于解热镇痛的注射用组合物 | |
KR100645268B1 (ko) | 동물약품용 약제학적 조성물 | |
WO2008098586A1 (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
BR102020014414A2 (pt) | Formulação contendo análogo de nucleosídeo em associação com lisina para o tratamento e profilaxia do herpes | |
CN103037842B (zh) | 药物化合物 | |
WO2022031744A2 (en) | Method and composition of upregulating rna interference process | |
CN109432419A (zh) | 一种免疫佐剂、灭活疫苗及其制备方法 | |
WO2014201914A1 (zh) | 一种吡喹酮-甲苯咪唑纳米乳口服液及其制备方法 | |
TW201622711A (zh) | 外用醫藥組成物 | |
TH83579A (th) | องค์ประกอบ | |
TH83579B (th) | สารผสม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: THE FIRST MEDICAL HEALTH CARE CO., LTD. Free format text: FORMER OWNER: YINMU NUOKOU PIYA CO., LTD. Effective date: 20141210 Owner name: YINMU NUOKOU PIYA CO., LTD. Free format text: FORMER OWNER: BIOCOPEA LTD. Effective date: 20141210 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141210 Address after: London, England Applicant after: InFirst Healthcare Ltd. Address before: Dublin, Ireland Applicant before: Yin Kou Ethiopia Co.,Ltd. Munuo Effective date of registration: 20141210 Address after: Dublin, Ireland Applicant after: Yin Kou Ethiopia Co.,Ltd. Munuo Address before: London, England Applicant before: BIOCOPEA Ltd. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130102 |